Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today announced the release of its redesigned Microvolt T-Wave Alternans (MTWA) software for its HearTwave II and CH2000 platforms. The new software release includes a significantly updated user interface and patient database, and supports industry integration standards into electronic medical record ("EMR") environments. The new software will help physicians streamline the practice workflow and allow them to access a patient's test results electronically through their EMR systems. The new software supports major industry reporting standards including HL7 and DICOM, optimizing connectivity to leading electronic medical records systems in the market. The software will be available to all existing and new customers and will begin shipping in May.
Ali Haghighi-Mood, CEO of Cambridge Heart, said, "This new software will enable our customers, particularly multi-physician practices and hospitals, to realize an increase in the usability of our products, and supports their goals of a transition into EMR environments by providing compatibility with industry standards. The new user interface and database were developed in response to our customers' requests to enable more efficient use of our products when performing MTWA testing."
Research uncovers enzyme essential for maintaining heart health